Fujifilm invested in the construction of a cell culture medium production base
Recently, Fujifilm announced that it will invest 188 million US dollars to establish a new cell nutrient medium production base in the United States.
Culture medium is a necessary medium for cell culture of biopharmaceuticals and regenerative medical products, and the market demand is constantly growing. Fujifilm's move is aimed at meeting the supply to pharmaceutical companies and research institutions.
It is said that this investment will build a new production base in North Carolina with a total construction area of 23,500 square meters. The project will start in the spring of 2023 and be completed and put into use in 2025. The new production base will be operated by Fujifilm's subsidiary in the United States. The annual production capacity of the new base is 3300 kiloliters of liquid media and 800 tons of powder media.
In addition, Fujifilm has production bases in California, the Netherlands and Japan. With the new North Carolina facility, the company will nearly triple its current production capacity for liquid media and nearly double its current production capacity for powder media.
2026-10-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Fujifilm to Invest €25 Million in Semiconductor Material Production Capacity in Belgium
-
Kaneke supplies raw materials to Fujifilm to increase production of Avigan
-
BASF increases prices for MDI in ASEAN countries
-
Dow Chemical Weighs Exit from $20 Billion Chemical Joint Venture with Saudi Aramco
-
Europe’s “Circulatory Defense”: BASF Quietly Ramps Up BDO — Not to Make Money, but to Survive
-
Covestro’s Sudden MDI Price Hike: What’s Really Rising Isn’t $220, but Pricing Power in North America’s Polyurethane Industry
-
Losses Persist, Yet Huntsman Raises Prices — A Quiet Turning Point in the MDI Cycle
-
Trump Places Glyphosate Under the Defense Production Act, Turning Bayer from a Corporation into a “National Asset”
-
Trump Places Glyphosate Under the Defense Production Act, Turning Bayer from a Corporation into a “National Asset”
-
Wanhua Chemical Is Fighting Counterfeits While Raising Prices
Recommend Reading
-
SABIC Agri-Nutrients Advances Mega Fertilizer Expansion With 1.2 Million MT/Year Ammonia Plant
-
Lier Chemical Gains Momentum as Chlorantraniliprole Supply Stabilizes
-
Westlake to Shut Cologne PVC Plant in $205M Exit
-
$14.5 Billion Solstice–Element Solutions Merger Abruptly Terminated Less Than Two Months After Announcement
-
Production Down 6%, Profits Cut by $3.7 Billion: Middle East Conflict Hits ExxonMobil Hard
-
Premium Global Chemical Sourcing Requests (2-7Oct.,2026)
-
U.S. Finds Chinese Potassium Phosphate Dumping Could Recur at Margins Up to 95.40%
-
Gellan Gum (E418): Vegan Thickener vs. Xanthan Gum in Food
-
U.S. Finds Methionine Dumping Could Recur, With Japan Margin Up to 76.50%
-
Address Change Declaration(ECHEMI SPECIALTIES)